CODELAB CAPITAL |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.828 NOK | +3.50% |
|
-4.61% | +67.61% |
| 2023 | CodeLab Capital AS Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Transcript : CodeLab Capital AS, Q1 2023 Earnings Call, May 25, 2023 |
| Sales 2021 | 209M 18.92M 1.58B | Sales 2022 | 195M 17.65M 1.47B | Capitalization | 303M 27.53M 2.3B |
|---|---|---|---|---|---|
| Net income 2021 | -91M -8.25M -688M | Net income 2022 | -156M -14.15M -1.18B | EV / Sales 2021 | 3.49 x |
| Net cash position 2021 | 27.33M 2.48M 207M | Net Debt 2022 | 162M 14.67M 1.22B | EV / Sales 2022 | 2.39 x |
| P/E ratio 2021 |
-8.23
x | P/E ratio 2022 |
-1.94
x | Employees | 200 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 8.71% |
More Fundamentals
* Assessed data
More news
Latest transcript on CodeLab Capital
More press releases
| 1 day | +3.50% | ||
| 1 week | -4.61% | ||
| Current month | -19.22% | ||
| 1 month | -19.22% | ||
| 3 months | +176.00% | ||
| 6 months | +15.00% | ||
| Current year | +67.61% |
1 week
0.76
0.89
1 month
0.761.13
Current year
0.301.98
1 year
0.301.98
3 years
0.3011.00
5 years
0.3017.48
10 years
0.3017.48
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | - | 01/14/01 | |
Kristian Ikast
CEO | Chief Executive Officer | - | 23/20/23 |
| Founder | - | 01/14/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 44 | 23/20/23 | |
Kristian Ikast
CEO | Chief Executive Officer | - | 23/20/23 |
| Chairman | - | 05/17/05 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 0.828 | +3.50% | 55,677 |
| 25/24/25 | 0.8 | -3.38% | 115,715 |
| 24/24/24 | 0.828 | -1.43% | 334,553 |
| 23/24/23 | 0.84 | +1.45% | 422,610 |
| 22/24/22 | 0.828 | -4.61% | 636,306 |
Real-time Oslo Bors, April 26, 2024 at 08:15 pm IST
More quotes
Codelab Capital AS, formerly Patientsky Group AS, is a Norway-based Information Technology (IT) solutions provider. The Company is developing eHealth solutions for global healthcare and offers both Software-as-aService (SaaS), Platform-as-a-Service (PaaS) and Value-Added Services (VAS) solutions to healthcare providers and their patients. The Company's main products are the PatientSky 360 Platform, electronic health record systems and medication modules. The PatientSky 360 Platform is the core of the group's business, and is a platform that provides all the necessary building blocks for internally and partner developed modules of scalable healthcare software.
Calendar
28/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +67.61% | 15.28M | |
| +4.36% | 32.47B | |
| +14.14% | 7.45B | |
| +22.93% | 3.89B | |
| -16.29% | 3.17B | |
| -25.96% | 1.28B | |
| -36.14% | 1.09B | |
| -35.42% | 902M | |
| -0.13% | 893M | |
| -24.12% | 857M |
- Stock Market
- Equities
- PSKY Stock
